Clinical Pharmacological Issues in the Elderly
|
|
- Clarence Reed
- 6 years ago
- Views:
Transcription
1 Clinical Pharmacological Issues in the Elderly Charles A. Cefalu MD, MS Professor and Chief, Section of Geriatric Medicine Department of Med, LSUHSC, New Orleans, La. Evaluation for Possible Polypharmacy 85 yr. olds and older; average 5-8 drugs per patient Association exists between increased number and severity of illnesses and increased number of adverse drug reactions Ref: Lesar, Briceland, and Stein, JAMA, 277,1997, p
2 Increased Medication Use and Perceived Health in the Oldest Old Increased medication use associated with poorer ratings on health self report Not associated with increased mortality except for use of digoxin Ref: Hershman DL et al. Drug utilization in the old and old and how it relates to selfperceived health and all-cause mortality: results from the Bronx Aging Study. J Am Geriatr Soc. 43(4), Apr 1995, p Factors Related to Adverse Drug Drug Reactions Chronicity and Multiplicity of Disease Increased Disease-Drug Interactions Increased Drug-Drug Interactions Lanoxin and Quinidine Theophylline and Erythromycin Visiting Multiple Prescribers Visiting Multiple Pharmacies Ref: Schwartz JB. Clinical Pharmacology. In: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th Ed., 2000, p. 326.
3 Factors Related to Increased Number of Adverse Drug Reactions, Cont d Multiple Diseases CHF COPD PVD CRF Chronic liver disease Dementia ASHD Diabetes Mellitus Osteoporosis DJD Others Normal Changes of Aging Increased Fat Decreased Bone Decreased Muscle Decreased Water Content Ref: Cefalu CA. Clinical Pharamcology. In: Burke MM & Laramie JA. Primary Care of the Older Adult. 2000, p. 90.
4 Normal Physiological Changes of the Organ Systems Liver- decreased blood flow; Decreased Phase I Metabolism Kidney- decreased creatinine clearance with advanced age CNS-increased risk of confusional states primarily secondary to anti-cholinergic agents Intestinal tract-- malabsorption-- not clinically significant in absence of disease Normal Changes of Aging-Hepatic Phase I Metabolism-rate of metabolism slows (oxidation, reduction, hydroxylation) Phase II Metabolism-rate stays the same (conjugation or deactivation processsulfonuralidation, methylation, acetylation) Examples-benzodiazepines Short acting-phase II only-appropriate Long acting-phase I and II-inappropriate, long half-lives Reference: Beers MH. Medication Use in the Elderly. In: Calkins, Ford & Katz, 1992, p. 40. Pharmaceutical Agents That Require Hepatic Metabolism NSAIDs; Aspirin Acetaminophen Erythromycin Ketoconazole Tetracyclines Lidocaine Metoprolol SSRIs Ca channel blockers Alpha blockers Statins Dilantin Valproic acid Carbamazepine Tricyclic Antidepres Neuroleptics
5 Pharmaceutical Agents That Require Hepatic Metabolism Benzodiazepines Cimetidine Ranitidine Famotidine Terfenadine Proton pump inhibitors Schwartz JB. Clinical Pharmacology. In: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th Ed., 2000, p The Cytochrome System CYP1A2 CYP2C CYP2D6 CYP3A Involves Model Compounds, Drug Substrates, Inducers, and Inhibitors Ref: Schwartz JB. Clinical Pharmacology. In: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th Ed., 2000, p Particular Agents of Concern in the Elderly-highly bound to protein Phenytoin Carbamazepine Barbiturates Warfarin Malnutrition or hypoproteinemia is associated with increased free fraction of drug and increased toxicity Ref: Physicians Desk Reference, Medical Economics- Thomson Healthcare,55 th Edition, 2001, p
6 Normal Changes of Aging-Renal Age-related reduction in renal blood flow and creatinine clearance in the face of a normal BUN and serum creatinine: Implications- Adjust dose of renally excreted drugs with age according to the following formula Creatinine Clearance Calculation Cr Clearance= (140-age) x weight (kg) serum creatinine x 72 (serum cr adjusted to 1, multiplied x.85 for female) Ref: Ref: Cefalu CA. Clinical Pharmacology. In: Burke MM & Laramie JA. Primary Care of the Older Adult. 2000, p. 92. Pharmaceutical Agents Primarily Eliminated In the Kidneys Requiring Dosage Adjustment Penicillins Procainamide Aminoglycosides Atenolol Fluroquinolones Clofibrate Lithium Ace Inhibitors Digoxin Metformin Fluconazole Bisphosphonates Thiazides Nizatidine Ref: Schwartz JB. Clinical Pharmacology. In: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th Ed., 2000, p
7 Inappropriate Prescribing of Renally Excreted Agents in LTC One in three renally excreted drugs prescribed in Ontario nursing homes was inappropriately dosed based on the calculated creatinine clearance. Renal function is often overlooked when prescribing renally excreted drugs to older longterm care residents and emphasizes the need for consideration of creatinine clearance when prescribing such drugs in this population. Ref: Papaioannou A et al. Assessment of Adherence to renal dosing guidelines in long-term care facilities. J Am Ger Soc. 48(11), Nov. 2000, p Aminoglycoside Dosing in the Elderly With Impaired Renal Function Once daily dosing of aminoglycosides associated with reduced risk of morbidity (ototoxicity and renal failure) in patients with reduced creatinine clearance (usually below 50 ml/minute). Also alleviates the need for expensive peak and trough testing. Ref: Cefalu CA & Agcaoli D. Preventing antibiotic misuse in older patients. Hospital Medicine, December 1998, p Good Rule of Thumb Reduce by half the dose of the particular renally excreted agent with a creatinine clearance of 50 ml/minute or less.
8 Physiological changes of the GI Tract Stomach- little change in gastric acidity with aging. In presence of dsyphagia and H2 blocker therapy, may increase risk of morbidity and mortality from pneumonia (bacteria more viable after aspiration due to reduced acidity) Decreased GI motility and blood flow-- increased frequency of constipation Ref: In: Hall KE, Wiley JW. Age-Associated Change in Gastrointestinal Function. In: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th Ed., 2000, p CNS Changes with Aging Reduced numbers of receptors Subtle structural and physiological changes consistent with Alzheimer's and Vascular Dementia Increased susceptibility to drugs with anticholinergic properties resulting in: urinary retention; constipation; dry mouth; blurred vision; sedation; cognitive dysfunction Ref: Cefalu CA. Clinical Pharmacology. In: Burke MM & Laramie JA. Primary Care of the Older Adult. 2000, p. 90.
9 Anticholinergic Agents Phenothiazine major tranquilizers (promethazine, thorazine, chlorpromazine, haloperidol) Tricyclic anti-depressants (imipramine, amitriptyline, nortriptyline, desipramine) Narcotics-demerol, codeine, morphine Anti-spasmotics-oxybutynin, diclomine, tolterodine, probanthine, atropine, hyoscyamine, probanthine, belladonna alkaloids Anti-cholinergic Agents-continued Anti-histamines Diphenhydramine Cyproheptadine OTC cold medications OTC sleep agents Trihexyphenidyl Benztropine
10 Common Clinical Conditions Necessitate Adjustment of Dosage in the Elderly: Liver- cirrhosis, malnutrition, malignancy, hepatitis with resultant decreased albumin and total protein levels (ex: sodium warfarin and phenytoin Kidney- chronic renal insufficiency, renal failure Brain-dementia, delirium Intestinal tract- malabsorption syndrome stomach- gastritis, malignancy Anorexia and Aging Reduced thirst and appetite with normal aging Reduced thirst and appetite is associated with depression and/or dementia Ref: Singh MAF & Rosenberg IH. Nutrition and Aging. IN: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th Ed., 2000, p. 88. Anorexia-Drug Induced: Theophylline Macrodantin Pronestyl Digoxin Thyroxin SSRIs Ref: Thompson MP, Morris LK. Unexplained Weight Loss In the Ambulatory Elderly. J Am Geriatr Soc. 39, 1001, p
11 Specific High Risk Drug Categories Screening for potential toxicity of prescription drugs-h2 Blockers: Confusion at high doses- Creatinine clearance below 50/ml/min.= reduce dose, except famotidine (below 20 ml/min) Nonspecific use associated with inadequate healing of gastric and duodenal ulcerations and greater chance of recurrence Nonspecific use for prophylaxis when used with NSAIDs Only two specific indications for prophylaxis to prevent gastrointestinal bleeding in the ICU setting: respiratory failure or coagulopathy H2 Blockers-continued Very common to use these agents in nursing home without specific indications Ref: Cefalu CA. Clinical Pharmacology. In: Burke MM & Laramie JA. Primary Care of the Older Adult. 2000, p. 93.
12 High Risk Drugs-Beta Blockers B-Blockers (propranolol)-side effects of: Precipitation of or exacerbation of CHF Masking of hypoglycemia Development of hypotension Masking of symptoms of endocrine disease (hypothyroidism). Reduction in exercise capacity Exacerbation of chronic lung disease or bronchospasm Depression Memory loss Production of arthropathy Ref: Cahill et al: Beta-adrenergic activation and memory for emotional events, Nature, 371, P Newbern et al. Cautionary Tales on Using Beta Blockers. Geriatric Nursing. 12(3); 1991, p Beta Blockers-continued use selective ones: atenolol and metoprolol Less side-effect profile Better compliance-once or twice daily Use associated with reduced cardiovascular morbidity and mortality in high risk patients Ref: Mangano DT et al. Effect of atenolol on mortality and cardiovascular morbidity after non-cardiac surgery. N Engl J Med, 335, 1996, p Australia/New Zealand Heart Failure Research Collaborative Group, 1997 Antihypertensives that cause Postural Hypotension or Sedation: Alpha-methyl-dopa Clonidine Alpha-blocking agents: useful for combined hypertension and prostatic hyperplasia Reserpine Ismelin- same as reserpine Physicians Desk Reference, 2003
13 Diuretics Once daily dosing increases compliance Inexpensive First line agents effective in reducing risk of stroke and CV disease Doses above 50 mg ineffective in achieving blood pressure control Thiazides generally not effective in the presence of renal insufficiency May cause hypercalcemia Contribute to or cause incontinence Use not associated with adverse effects on lipids Diuretics-continued Use in older caucasian women associated with reduced risk of hip fracture Adverse reactions Dehydration; postural hypotension; K loss (especially during the summer and sweating) Consider discontinuing in elderly when possible, especially advanced, demented, or depressed elderly (reduced thirst and appetite drive)
14 Diuretics-References Ref: SHEP (Systolic Hypertension in the Elderly) Cooperative Research Group, 1991 Heidrich et al. Diuretic drug use and the risk of hip fracture Ann Intern Med., 115, 1991, p Physicians Desk Reference, 2003 Gurwitz MM et al. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis. J Am Geriatr Soc., 45(1), Jan. 1997, p
15 Major and Minor Tranquilizers* and Hypnotics: Worsen dementia and delirium Cause hip fractures and falls Cause postural hypotension Risk of tardive dyskinesia with phenothiazines *Especially long acting minor and sedating, highly anti-cholinergic major ones Ref: Cefalu CA. Clinical Pharmacology. In: Burke MM & Laramie JA. Primary Care of the Older Adult. 2000, p Newer Atypical Antipsychotics: Much less risk of tardive dyskinesia Much more expensive Olanzepine most anti cholinergic and sedating Risperidol-increased risk of CVA, works through dopaminergic mechanism SSRIs May cause Falls Nuisance side effects-nausea, decreased appetite, insomnia, agitation Void of cardiac risks compared to tricyclic antidepressants Inappropriate-
16 Oral Hypoglycemics: Cause Hypoglycemia-- chlorpropamide SIADH more frequent with aging (idiopathic 30%) Lanoxin (Few indications currently for use except for rate control or congestive heart failure to improve function). Side-effects: Confusion Anorexia Nausea Yellow Green Colors Agitation Depression Ref: Physicians Desk Reference, 2003; Geriatrics Review Syllabus, 5 th Ed., , p. 260 NSAIDs*: Can Worsen HBP- removal of NSAID can affect mean blood pressure control Fluid retention Worsen CHF Cause confusion GI bleeding Newer Cox-2 agents, gastric sparring Less risk of Alzheimer's and cognitive decline *In big doses or used chronically Ref: Carson JL & Strom BL. Use of Nonsteroidal Anti-Inflammatory Drugs. In: Hazzard WR et al. Principles of Geriatric Medicine and Gerontology, 4 th Ed., 2000, p ; Stewart WF et al. Risk of Alzheimer s disease and duration of NSAID use. Neurology, 48, 1997, p
17 Tips for Safe Traditional NSAID Use Substitute acetaminophen when possible around the clock instead of NSAID Use PRN when possible Use lowest dose possible Use for acute flare for 7-10 days then d/c When necessary for chronic use, insist on routine q 3 month BUN and CBC Narcotics: May cause cognitive dysfunction Have anti-cholinergic side effects urinary retention constipation dry mouth sedation Theophylline Adverse Reactions: Anorexia Nausea Arrhythmias Hypotension Drug-drug interactions-erythromycin, cimetidine, diazepam, phenytoin Useful for acute wheezing or asthma, not for COPD Ref: Physicians Desk Reference, 2003; Cefalu CA. Clinical Pharmacology. In: Burke MM & Laramie JA. Primary Care of the Older Adult. 2000, p. 112.
18 Oxybutynin Anticholinergic-(XL form with less side effects) Sedation Cognitive dysfunction Dry mouth Blurred vision Constipation Urinary retention Ref: IR Katz et al. Identification of medications that cause cognitive impairment in older people: The case of oxybutynin chloride. J AM Geriatr Soc., 46, 1998, p Sedation Falls Muscle Relaxers: Anti-cholinergic side-effects Contraindicated in elderly Ref: Physicians Desk Reference, 2003 Ophthalmologic Preparations Beta blocker preparations-can achieve significant systemic absorption leading to heart block, CHF, bronchospasm. Physicians Desk Reference, 2003
19 List Of Inappropriate Drugs In Elderly- Journal of American Medical Association-July 27, 1994; Archives of Internal Medicine-July 28, 1997 and revised 2003 Inappropriate Drugs in Elderly: Diazepam Chlordiazepoxide- long acting Flurazepam- long acting Muscle relaxers- sedation, anticholinergic Vasodilators- ineffective, cause Steal Syndrome and postural hypotension-of historic interest only, no longer available Dipyridamole- ineffective Amitriptyline- sedation, anticholinergic Propranolol-??? J of Am Med Assoc, July, 1994, Arch of Int Med, July, 97,
20 Inappropriate Drugs in Elderly- Cont,d Alpha-methyl dopa (Aldomet) Depression Hemolytic anemia Drug-induced lupus Inappropriate Drugs in Elderly- Cont,d Fluoxetine-long acting, may cause weight loss and anorexia Reserpine (cheap and once per day, ganglionic blocking agent) Depression Impotence Sedation Orthostatic hypotension Inappropriate Drugs in Elderly- Cont,d Short-acting Benzodiazepines in excess of the following doses: Lorazepam- 3mg Oxazepam- 6mg Alprazolam- 2mg Temazepam- 15mg Zolpidem- 5mg Triazolam-.25mg
21 Inappropriate Drugs in Elderly- Cont,d Anticholinergic Diclomine Hyoscyamine Probanthine Belladonna alkaloids Inappropriate Drugs in Elderly- Cont,d Chlorpropamide-very old drug!!!-of historic interest only, not available Indomethacin (neurotoxic)- confusion, bleeding Propoxyphene- sedation and no more effective than acetaminophen Trimethobenzamide- extra-pyramidal sideeffects and least effective anti-emetic Pain Pill Use by Elders Lack of adequate pain assessments, little use of nonpharmacologic interventions, and inappropriate use of analgesic medication in the nursing home (Ref: Cramer GW et al. J Am Geriatr Soc, 48(4), March 2001, p Use of proxyphene in the community dwelling elders is 6.8% and double this in th elong-term setting-15.5%. Ref: Sachin JK et al. J AM Geriatr Soc., 51, 2003, p
22 Inappropriate Drugs in Elderly- Cont,d Pentazocine- sedation, confusion, and hallucinations Meprobamate- addictive and sedating-very very old drug-of historic interest only, not available Lanoxin (if higher than.125mg)- reduced renal clearance with normal aging Disopyramide- negative inotropic effect, may cause CHF, off the market-of historic interest only, not available Inappropriate Drugs in Elderly- Cont,d Phenylbutazone- excess bleeding, not available, of historic interest only Doxepin- anticholinergic and sedating Ticlopidine- no more effective than aspirin, not available, of historic interest only Meperidine- addicting, short-acting associated with breakthrough, sedation, anticholinergic Barbiturates- sedation Clonidine-sedating Inappropriate Drugs in Elderly- Cont,d Iron in doses greater than 325mg iron sulfate- constipation and no greater absorption at higher dose
23 Screening for Toxicity of OTC Drugs Laxatives- chronic use associated with development of chronic megacolon, terminal reservoir syndrome, subsequent fecal impaction, and cancer Vitamins A, C and E- added toxicity with little added benefit Acetaminophen or aspirin- several different doctors, different brand names Screening for Toxicity-OTC Drugs-Cont. Especially diphenhydramine-containing OTC agents Sleep aides Cold Medications
24 Rules for Prescribing to the Elderly Start with one-third to one-half the normal starting dose Use one drug to treat two clinical conditions PAT and HBP HBP and angina Rules, cont d Maximize dose of one agent before adding second agent to treat same clinical condition (HBP) Less confusing for elderly Less expensive Less risk of adverse drug reactions Maximize compliance to no more than once or twice daily Rules, cont d Use cheapest drug possible Review medications patient brings in at each visit Discontinue unnecessary drugs and taper psychotropic drugs when possible
Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition
Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria
More informationAging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace
Aging and Geriatric Assessment Page 1 Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace I. Aging A. Demographics Age 65+ population 3.1 million 1900 31.2 million
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationPrescribing Drugs to the Elderly
Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering
More informationSTOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationSTOPP START Toolkit Supporting Medication Review in the Older Person
STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,
More informationSafe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science
Safe Medication Use in the Older Adult Holly Divine, PharmD, CGP, CDE Associate Professor University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science Objectives Know the principles
More informationGeriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationChitra Fernando, MD March 18, 2008
Chitra Fernando, MD March 18, 2008 Definition Statistics Risk factors Why older adults are more prone to ADE Manifestations Inappropriate medications for older adults What can be done to minimize adverse
More informationPrescribing and Pharmacokinetic Considerations in the Elderly
Prescribing and Pharmacokinetic Considerations in the Elderly Melanie A. Dodd, Pharm.D., Ph.C., BCPS Associate Professor of Pharmacy in Geriatrics College of Pharmacy The University of New Mexico OBJECTIVES
More information20.9 15.4 3.1 0.1 0.2 0.2 0.3 0.4 0.6 0.9 1.5 2.2 9.6 6.1 7.3 4.2 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040 2050 All Ages Age 65+ Age 85+ Female 50.9% Male 49.1% Female
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationPolypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017
Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Las Vegas 2017 Disclosure I have no current affiliation or financial arrangement with any grantor or commercial
More informationPolypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017
What is Polypharmacy Polypharmacy: What the Nurse Practitioner Should Know Audrey M. Stevenson PhD, MPH, MSN, FNP-BC Nashville, TN 2017 The use of multiple medications simultaneously Rx OTC Herbal Disclosure
More informationBEERs For the Elderly
BEERs For the Elderly February 2008 Presented by:carla Ambrosini Seniors First Clinic Pharmacist 12/05/2008 1 Objectives To highlight the overall health care impact of drug related adverse reactions and
More information1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA
UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical
More informationPharmacology in the Elderly
Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol
More informationPOLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE
POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationAn approach to prescribing in the elderly. Preamble
An approach to prescribing in the elderly Dr K Outhoff Preamble Advances in medical technology, surgical procedures, medical practice and innovative drug development An increasing proportion of the population
More informationPitfalls in Pharmacotherapy of Geriatrics
Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD) Case Study An 85 year old female with a history of atrial fibrillation, stroke, dementia, and hypertension, who is receiving chronic
More informationMaximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016
Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day
More informationDefinition and Statistics
Objectives 1. Describe the basic principles of how drugs work in the body and with one another. Nanette R Wrobel, RPh Director of Education/Clinical Director Pharmacy Alternatives 2. Identify the four
More informationMedication Use in Older Adults
Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division
More informationDelirium. Assessment and Management
Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about
More informationDrug Interactions Year 2 Clinical Pharmacology
1 Drug Interactions Year 2 Clinical Pharmacology Prof Mark McKeage Department of Pharmacology & Clinical Pharmacology 2 Objectives Explain the potential for interacting drugs to cause beneficial and harmful
More informationPharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007
Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual
More informationCHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS
CHAPTER 2. GERIATRICS, SELF-ASSESSMENT QUESTIONS 1. The following is an accurate description of the aging population: A. The number of older adults will reach 17 million in 2030 B. The ratio of women to
More informationPrevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College
Prevention of Medication-Related Falls Through Appropriate Medication Use Clay Sprouse, MEd., CPhT Piedmont Technical College Disclosure I have no relevant financial or nonfinancial relationships to disclose
More informationGI Pharmacology. Dr. Alia Shatanawi 5/4/2018
GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Drugs Used in Gastrointestinal Diseases Drugs used in Peptic Ulcer Diseases. Drugs Stimulating Gastrointestinal Motility &Laxatives. Antidiarrheal Agents. Drugs
More informationPreventing Falls in Older Adults A Matter of Safety
Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview
More informationSTART, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy
START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment
More informationIntelligent Polypharmacy. Professor Colin P Bradley Department of General Practice University College Cork
Intelligent Polypharmacy Professor Colin P Bradley Department of General Practice University College Cork Polypharmacy No standard definition 2005 review the use of medications that are not clinically
More informationPresenter. Dr. Ronald Lucchino
Adverse Drug Reactions in Adults with Down Syndrome Presenter Dr. Ronald Lucchino rvluc@comcast.net PURPOSE To increase staff awareness that older adults with DD may have higher levels of medication in
More informationPharmaceutical Care for Geriatrics
Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING
More informationPotentially Inappropriate Medication Use in Older Adults 2015 Latest Research
Home Resources Potentially Inappropriate Medication Use in Older Adults 2015 Resources Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Drugs and Categories of Drugs What these
More informationPHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS
1 PHARMACOTHERAPY IN THE OLDER PERSON NAMIRAH JAMSHED M.B;B.S ASSOCIATE PROFESSOR UTSW MEDICAL CENTER DALLAS OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics
More informationIntroductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs
Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available
More informationHow to Teach About Drugs and Aging
How to Teach About Drugs and Aging Brandon Koretz MD Assistant Clinical Professor Division of Geriatrics Challenges Prescription pad:internist::scalpel: Surgeon Artificial split between theory and practice
More informationChronic Obstructive Pulmonary Disease (COPD) Care Management Assessment
The questions in this brochure, based on the 2010 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, 1 are designed to help healthcare professionals (specifically case/care managers)
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationDelirium and Dementia
Delirium and Dementia Elder Friendly Care in Acute Care Seniors Health Strategic Clinical Network Acute Care Stress Blender Poor Poor sleep At-Risk Older Adult TREAT CAUSE immediately & aggressively. Increased
More informationMedications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy
Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion
More informationFriend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines
Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines Program Learning Objectives At the conclusion of the activity, participants should be able to: Have a basic understanding
More informationOBJECTIVES. Key issues in geriatric pharmacology. Effects of age on pharmacokinetics and pharmacodynamics
PHARMACOTHERAPY 1 OBJECTIVES 2 Know and understand: Key issues in geriatric pharmacology Effects of age on pharmacokinetics and pharmacodynamics Risk factors for adverse drug events for older patients
More informationBiology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.
Biology of Aging Aging Changes That Impact Medication Management Emily P. Peron, PharmD, MS, BCPS, FASCP Assistant Professor of Geriatrics Virginia Commonwealth University School of Pharmacy Richmond,
More informationManagement of Delirium in Hospice Patients
Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying
More informationA Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine
A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation
More informationPharmacotherapy In Geriatrics: Cause For Concern
http://www.dcmsonline.org/jax-medicine/1998journals/august98/geriatrics.htm Pharmacotherapy In Geriatrics: Cause For Concern Sherry A. King, M.D. Sherry A. King, M.D. is Clinical Assistant Professor of
More informationDRUGS, PREGNECY & NEWBORN
DRUGS, PREGNANCY & NEWBORN DRUGS, PREGNECY & NEWBORN By- Dr Raghuveer Ist By- PG Dept of Rasashastra Dr Raghuveer Dept of Rasashastra KVG Ayurvedic Medical College Sullia ayuraghu@rediffmail.com Introduction
More information2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY OVERALL PRESCRIBING
Mean # Drugs/Resident 2/25/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY Darrell R. Abernethy, M.D., Ph.D. Associate Director for Drug Safety
More informationAging Changes That Impact Medication Management
Biology of Aging Aging Changes That Impact Medication Management Emily P. Peron, PharmD, MS, BCPS, FASCP Assistant Professor of Geriatrics Virginia Commonwealth University School of Pharmacy Richmond,
More informationMeasure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety
Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2015 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES REGISTRY ONLY DESCRIPTION:
More informationUsing the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit
Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Target Audience: Pharmacists ACPE#: 0202-9999-18-056-L01-P Activity Type: Application-based Disclosures Kathleen
More information2/26/2015 PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY
PHARMACODYNAMICS OF AGING: NARROWING OF THE THERAPEUTIC INDEX IN THE FACE OF THERAPEUTIC OPPORTUNITY Darrell R. Abernethy, M.D., Ph.D. Associate Director for Drug Safety Office of Clinical Pharmacology
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS Frequently Asked Questions: Table of Contents How should pain be assessed in an unconscious patient? What is the cardiovascular risk associated with the use of nsnsaids/coxibs
More informationUniversity of Hawaii Center on Aging
University of Hawaii Center on Aging. Supported in part by a cooperative agreement No. 90AL0011-01-00 from the Administration on Aging, Administration for Community Living, U.S. Department of Health and
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationFalls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in
This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor
More informationInterface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE
Cholinesterase inhibitors and Memantine are now classified as green (following specialist initiation) drugs by the Greater Manchester Medicines Management Group. Who will diagnose and decide who is suitable
More informationDRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future
DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future Daniel S. Sitar Professor Emeritus University of Manitoba Email: Daniel.Sitar@umanitoba.ca March 6, 2018 INTRODUCTION EPIDEMIOLOGY
More informationDeprescribing Unnecessary Medications: A Four-Part Process
Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient
More informationDelirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018
Three most common cognitive problems in adults 1. (acute confusion) 2. Dementia 3. Depression These problems often occur together Can you think of common stimuli for each? 1 1 State of temporary but acute
More informationFall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)
Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who
More informationTricyclic Antidespressants: Actions
Introductory Clinical Pharmacology Chapter 24 Antidepressant Drugs Tricyclic Antidespressants: Actions Increase sensitivity in postsynaptic alpha (α)-adrenergic, serotonin receptors Decrease sensitivity
More informationMEDICATION APPROPRIATENESS FOR THE AGING POPULATION. Building Partnerships for Successful Aging
MEDICATION APPROPRIATENESS FOR THE AGING POPULATION Building Partnerships for Successful Aging Learning objectives Appreciate complexities involved in making appropriate clinical decisions in older adults
More informationMedication Prescribing for Older Adults
REVIEW Medication Prescribing for Older Adults Barbara Roehl, MD, MBA, Amy Talati, PharmD, and Susan Parks, MD The frequency of chronic illness increases with age. As a result, elderly persons receive
More informationAntidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.
More informationSummary of Delirium Clinical Practice Guideline Recommendations Post Operative
Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;
More informationDrugs that poison the elderly
Drugs that poison the elderly Brent Tipping Sub-specialist Geriatrician and Specialist Physician Division of Geriatric Medicine, Department of Medicine University of the Witwatersrand To treat or not to
More informationFamily Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD
Family Medicine for English language students of Medical University of Lodz Seminar 12 Elderly care Przemysław Kardas MD PhD Europe is facing demographic challenge 2014 2080 2 3 Old vs young: major differences
More informationSafe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA
Psychotropic Drugs Safe and Effective Use of Psychotropic Drugs JMAJ 47(6): 259 264, 2004 Jun NAKAMURA Professor, Department of Psychiatry, School of Medicine, University of Occupational and Environmental
More informationDiabetes and the Elderly: Medication Considerations When Determining Benefits and Risks
Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES
More informationQuality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety
Quality ID #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationFull details and resource documents available:
Clinical & Regulatory News by Pharmerica Urinary Tract Infection (UTI) Second Most Common Cause of Hospital Readmission within 30 days UTIs are prevalent and account for up to 22% of infections in LTC,
More informationDelirium. A Geriatric Syndrome. Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine
Delirium A Geriatric Syndrome Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine Introduction Common Serious Unrecognized: a medical emergency
More informationMeasure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety
Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationByvalson. (nebivolol, valsartan) New Product Slideshow
Byvalson (nebivolol, valsartan) New Product Slideshow Introduction Brand name: Byvalson Generic name: Nebivolol, valsartan Pharmacological class: Beta-blocker + angiotensin II receptor blocker (ARB) Strength
More information21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content
Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for
More informationAntipsychotic Use in the Elderly
Antipsychotic Use in the Elderly Presented by: Fatima M. Ali, PharmD, RPh, BCPS Clinical Consultant Pharmacist MediSystem Pharmacy, Kingston Originally Prepared by: Nicole Tisi BScPhm, RPh ACPR Disclosure
More informationMETOTRUST XL-25/50 Metoprolol Succinate Extended-Release Tablets
METOTRUST XL-25/50 Metoprolol Succinate Extended-Release Tablets COMPOSITION Each film-coated tablet of Metotrust XL-25 contains: Metoprolol Succinate USP 23.75 mg equivalent to Metoprolol Tartrate 25
More informationPolypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD
Polypharmacy and the Older Adult Leslie Baker, PharmD, BCGP Umanga Sharma, MD Objectives Identify what polypharmacy is Identify factors leading to polypharmacy Discuss consequences of polypharmacy Identify
More informationWhy Target Delirium for Surgical Quality Improvement?
Why Target Delirium for Surgical Quality Improvement? Tom Robinson MD FACS thomas.robinson@ucdenver.edu July 22, 2018 Disclosures Tom Robinson has no disclosures. Who Cares About the Brain? Acute Organ
More informationPotential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital
Potential Drug Dosing Variability in Women Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital 2 Objectives Understand the pharmacokinetic variability
More informationSIFROL â. Contraindications Hypersensitivity to pramipexole or any other component of the product.
SIFROL â Composition 1 tablet contains 0.088, 0.18 & 0.7 mg (S) 2 amino 4,5,6,7-tetrahydro-6-propylamino-benzothiazole (= pramipexole base) equivalent to 0.125, 0.25 & 1 mg of pramipexole dihydrochloride
More informationBehavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.
Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS
More informationAmal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region
Risks Of Polypharmacy Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region What is Polypharmacy? Polypharmacy means many drugs. In practice, polypharmacy refers to the use of more medication
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationRational prescribing in the older adult. Assoc Prof Craig Whitehead
Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationAnthony J. Caprio, MD, CMD, AGSF 1
Objectives 1) Discuss the dangers of polypharmacy 2) Review potentially inappropriate medications for older adults Doc, I think I am taking too many medications! 3) Develop strategies for prioritizing
More informationMeasure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety
Measure #238 (NQF 0022): Use of High-Risk Medications in the Elderly National Quality Strategy Domain: Patient Safety 2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY DESCRIPTION:
More informationResidents Who Don t Sleep
Residents Who Don t Sleep Case study........................................... An 86 yr. old woman has diagnoses of Alzheimer s disease, congestive heart failure, constipation, depression, hypertension
More informationSMOKING AND DRUG INTERACTIONS
Medicines Information Centre Pharmacy Department UK Medicines Information SMOKING AND DRUG INTERACTIONS Introduction Smoking rates are significantly higher among people with mental health problems. It
More informationPolypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics
Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse
More information